Posters

Format : Vertical A0 (841 x 1189 mm)

P1 – I. Sakharov (Lomonosov Moscow State University, Moscow, Russian Federation) Chemiluminescent label-free assays based on use of hemin aptamer

 

P2 – K. Peñaranda (Univ. Peruana de Ciencias Aplicadas, Lima, Peru ) New aptamer-based biosensors for the detection of Chagas Disease

 

P3 – F. Torrini (Univ . Florence, Florence, Italy) Development of a rapid detection strategy for cardiac Troponin T based on an Enzyme-Linked OligoNucleotide Assay (ELONA)

 

P4 – M. Ondruš (Czech Academy of Sciences, Prague, Czech Republic) Polymerase syntheses of sequence-specific monodispersed DNA polymers decorated by four different base-modified dNTPs

 

P5 – A. Kopylov, O. Antipova (Moscow State University, Moscow, Russian Federation) Prospects of EGFR aptamerotheranostics for glioblastoma

 

P6 – G. Pavlova (Russian Academy of Sciences, Moscow, Russian Federation) bi-HD1 (bi-TBA) reduces proliferation of linear lung cancer cells and human glioblastoma

 

P7 – V. Domenyuk (Caris Life Sciences, Phoenix, USA) Next Generation Proteomics Profiling of cancer patients by pre-enriched aptamer libraries and high-resolution mass-spectrometry

 

P8 – A. Sett (Univ. Bordeaux, Bordeaux, France) Light-up Aptamers- A tool for the detection of small molecules and biological ligands

 

P9 – A. Sett (Univ. Bordeaux, Bordeaux, France) Aptamers as a tool for selective targeting of muscle stem cells in Duchenne Muscular dystrophy

 

P10 – F. D’Aria (Univ. Napoli Federico II, Naples, Italy) Biophysics of DNA aptamers for Huntingtin targeting

 

P11 – G.M. Stovall (University of Texas, Austin, USA) Aptamers in Education

 

P12 – A. Salgado-Figueroa (Aptus Biotech, Madrid, Spain) TLR4 inhibition using a specific aptamer against receptor to suppress tumor development in breast cancer cells

 

P13 – P. M. Jurek (Pure Biologics, Poland) Modular platform for chemically modified aptamers

 

P14 – B. Kring Hansen (Aarhus University, Aarhus, Denmark) Developing fluorescent aptamer sensors using RNA Capture-SELEX

 

P15 – M. Flamme (Institut Pasteur, Paris, France) Towards the enzymatic formation of artificial metal base pairs with modified nucleotides

 

P16 – S. Breuers (CARD, Bonn, Germany) Center of Aptamer Research and Development (CARD)

 

P17 – I. Geraci (Univ. Bonn, Bonn, Germany) An RNA light-up sensor for probing cellular glycolytic-flux

 

P18 – M. Savonnet (Univ. Grenoble Alpes, Grenoble, France) Detection of troponin I by surface plasmon resonance imaging based on a sandwich assay using antibodies and aptamers

 

P19 – F. Levi-Acobas, L. McKenzie (Institut Pasteur, Paris, France) Evaluation of thiolated and pKa-perturbed nucleotides as potential candidates for an expansion of the genetic alphabet

 

P20 – T. Yoshitomi (University of Tokyo, Tokyo, Japan) Identification of Nuclease-resistant G-Quadruplex DNA aptamer with VEGF A-like activity

 

P21 – R. Nakamura (Univ. Tokyo, Tokyo, Japan) Circular bivalent thrombin aptamers having nuclease resistance and high anti-coagulant activity

 

P22 – P. Machtel (Polish Academy of Sciences, Poznan, Poland) New method for unbiased quantification of riboswitch transcriptional activity

 

P23 – A. Bouvier-Müller, C. Forier (CEA, Fontenay-aux-Roses, France) PATTERNITY-seq v4.0: Analyzing molecular evolution processes with unprecedented accuracy.

 

P24 – Z. R. Churcher (York University, Toronto, Canada) Characterization of the ochratoxin A-binding aptamer and binding to its ligand

 

P25 – C. K. O’Sullivan (Univ. Rovira i Virgili, Tarragona, Spain) High affinity aptamer for the detection of biogenic amine histamine

 

P26 – Y. Ahmadi (Austrian Institute of Technology, Vienna, Austria) HRP-mimicking based DNA aptazymes in diagnostics: Top or flop?

 

P27 – K. Švehlová (Institute of Organic Chemistry and Biochemistry, Prague, Czech Republic) Altered biochemical specificity of G-quadruplexes with mutated tetrads

 

P28 – C. K. O’Sullivan (Univ. Rovira i Virgili, Tarragona, Spain) Selection of aptamers against fragments of ciguatoxin for the development of aptamer based sandwich assay

 

P29 – C. K. O’Sullivan (Univ. Rovira i Virgili, Tarragona, Spain) Structure-switching aptamers binding the steroid hormone testosterone

 

P30 – A. A. Shoara (York Univ. Toronto, Canada) Analysis of Ligand-Induced Folding and Aptachain Self-Assembly in The Cocaine-Binding Aptamer

 

P31 – M. Menger (Fraunhofer IZI-BB, Potsdam, Germany) Two-state binding model of DNA aptamers for therapeutic anthracyclines

 

P32 – A. E. Sanchez-Castro (Univ.Peruana de Ciencias Aplicadas, Lima, Peru) Aptamer-mediated inhibition of bacterial initiation factor IF3

 

P33 – D. Bunka (Aptamer Group Limited, York, UK) Flexible Monitoring of Small Molecules with Aptamer Affinity Reagents

 

P34 – J. Siegl (Univ.Bonn, Bonn, Germany) Selection and characterization of chemically modified aptamers targeting CXCL9 as a diagnostic tool for renal allograft rejection

 

P35 – Z. Tolnai (Semmelweis Univ., Budapest, Hungary) Characterization of cardiac Troponin I specific spiegelmers

 

P36 – G. I. Mendoza-Ochoa (Univ. Cambridge, Cambridge, UK) Thiamine riboswitch for controlling transgene expression in the green alga Chlamydomonas reinhardtii

 

P37 – K. Percze (Semmelweis Univ., Budapest, Hungary) Generation of RSV F protein selective aptamers

 

P38 – K. Yoshimoto (University of Tokyo, Tokyo, Japan) Efficient Exclusion of Low-affinity Binders in Aptamer Selection by Microbeads-Assisted Capillary Electrophoresis (MACE) Separation

 

P39 – L. Kelly (Duke Univ., Durham, USA) In Vivo Localization of Fluorescently Labelled Aptamers for Informed Tumor Targeted Drug Delivery

 

P40 – S. Ali (Univ. Bordeaux, Bordeaux, France) Selective Targeting of Melanoma Biomarkers with DNA Aptamers

 

P41 – O. Puchta (Univ. Edinburgh, Edinburgh, UK) High-throughput screening of fluorescent RNA aptamers

 

P42 – E. Dausse, N. Tourasse (Univ. Bordeaux, Bordeaux, France) Development of aptasensors based on DNA kissing complex formation

 

P43 – S. P. Flanagan (Rhodes Univ., Grahamstown, South Africa) Aptamer development against Plasmodium vivax lactate dehydrogenase for the selective detection of malaria subspecies

 

P44 – D. Soukarié (Institut de Pharmacologie et de Biologie Structurale, Toulouse, France) A novel single DNA aptasensor for water quality monitoring

 

P45 – L. Azéma (Univ. Bordeaux, Bordeaux, France) Targeting Discoidin Domain Receptors with DNA aptamers

 

P46 – I. Ponzo (Dynamic Biosensors, Martinsried, Germany) A new surface DNA-based biosensor assay for the kinetic characterization of aptamer folding and interactions

 

P47 – A. Berlina (Institute of Biochemistry, Moscow, Russia) Nanoparticle-aptamer conjugates as a tool for heavy metals detection

 

P48 – N. Mamet (Bar-Ilan Univ., Ramat-Gan, Israel) Discovery of tumoricidal DNA aptamers by effect-directed in-vitro evolution

 

P49 – C. Frydman (HORIBA Scientific, Palaiseau, France) Multiplex detection of small molecules combining aptamers kissing complex and Surface Plasmon Resonance imaging technology: challenging on the rapidity and the sensitivity

 

P50 – E. Lantero (Institute for Bioengineering of Catalonia, Barcelona, Spain) Identification of DNA Aptamers against Plasmodium falciparum

 

P51 – Z. Murray (Victoria Univ. Wellington, Wellington, New Zealand) The use of HT-SELEX to investigate the effect of different selection strategies on the development of aptamers for small molecules

 

P52 – J. H. R. Tucker (Univ. Birmingham, Birmingham, UK) New Optical Methods for Detecting Aptamer Targets and Controlling their Catalytic Function

 

P53 – J. Leblond Chain (Univ. Bordeaux, Bordeaux, France) Improvement of specific loading and drug release using aptamer-based liposomes